Our Infrastructure

Our Equipment

The CIC’s offices were relocated to the first floor of the ICM building in 2011, bringing them closer to the research teams, technical facilities, and business incubator at the Brain Institute, thereby facilitating the development of translational research.

We offer comprehensive facilities to ensure optimal support for participants and projects, including dedicated spaces for medical care, consultations, blood draws, and treatment management.

The CIC Neurosciences is a 1,000-square-meter facility designed for research and participant care.

Reception of participants (patients or healthy volunteers)
Support and Care

4 consultation rooms

8 outpatient chairs (spread across 2 large rooms)

6 bedrooms with beds and bathrooms

1 dining room for patients and volunteers

1 laboratory for processing biological samples, equipped with 5 centrifuges

1 treatment preparation room

1 ECG room

1 food pantry

1 bathroom and restroom accessible to people with disabilities

1 patient toilet

Management of Experimental Treatments
Office spaces
Logistics Area

Storage and supply rooms

Freezer rooms (-80°C, -20°C), refrigerators (+4°C), all equipped with calibrated sensors

Data storage (rolling archives)
Operations and Staff

1 meeting room

1 room for photocopiers and computer equipment

1 IT department

1 lounge

1 bathroom

2 changing rooms with showers

The CIC collaborates with numerous platforms, research institutions, healthcare services and F-CRIN networks. These interactions are essential for the proper conduct of clinical trials. Close ties exist between the CIC and:

The Brain Institute's platforms

These platforms are equipped with advanced technologies such as brain imaging via CENIR or exploring real-world behavior via the platform PRISME (https://institutducerveau-icm.org/en/platforms-technology-apps/). CENIR has two 3T MRI scanners (Siemens Prisma and Cima X), one 7T MRI scanner (Siemens), and one PET-MRI scanner. The DNA and Cell Bank https://institutducerveau.org/resource-platform-biological-DNA-bank-cells allows samples to be stored for later analysis.

Partner services of the hospital group

CIC works very closely with Reqpharm (https://pitiesalpetriere.aphp.fr/reqpharm/) which is the pharmacy dedicated to clinical trials at the Pitié-Salpêtrière Hospital or other healthcare departments involved in patient care (Sleep Disorders Department, EFR, etc.).

Partner research centers or hospitals

The CIC works in partnership with other organizations on specific projects. This collaboration allows for the pooling of resources and expertise (e.g., CEA Paris-Saclay / https://www.cea.fr/paris-saclay/Pages/Home.aspx) and/or access to a specific population of patients eligible to participate in clinical trials (Example: Hôpital National des Quinze-Vingts / https://www.15-20.fr)

The F-CRIN Networks

These networks are national networks recognized by the National Research Agency. The CIC works in close collaboration with thematic networks in neurology, such as NS-PARK (https://parkinson.network) for Parkinson's disease, ACT4ALS (https://portail-sla.fr/act4als-mnd/) for Amyotrophic Lateral Sclerosis, or FCRIN4MS (https://www.fcrin4ms.org) for multiple sclerosis. The latter two are housed within the CIC.

Key Contributions

Resources at the Pitié-Salpêtrière Hospital

Access to advanced medical and technological facilities at a world-renowned hospital, enabling comprehensive care for complex neurological conditions.

Collaboration with the Neuroscience Department

Integration with the University Medical Department of Neuroscience, fostering close collaboration between clinical research and patient care

Partnership with the Brain Institute (ICM)

Daily interaction with the research teams at the ICM, one of the world’s leading neuroscience research centers, ensuring direct access to the latest scientific advances.

Strategic Alliance with Neurotrials

Supported by the Brain Institute, Neurotrials is its early-stage development unit dedicated to developing new therapeutic approaches for neurological diseases

Facilitated Translational Research

Synergy between basic and clinical research, enabling discoveries to be rapidly translated into concrete treatments, thereby accelerating the development of innovative therapies.

Industrial and Institutional Partnerships

Strategic partnerships with companies in the pharmaceutical and medical sectors, strengthening our expertise and capabilities in developing therapeutic solutions on a large scale.